The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Final results for the AVAST-M trial.
 
Philippa Corrie
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb; Celgene; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Andrea Marshall
No Relationships to Disclose
 
Paul Lorigan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Martin Eric Gore
No Relationships to Disclose
 
Saad Tahir
Travel, Accommodations, Expenses - PharmaMar
 
Guy Faust
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; MSD
 
Charles G. Kelly
Consulting or Advisory Role - MSD
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Maria Marples
Honoraria - Roche
Consulting or Advisory Role - Pierre Fabre
Research Funding - Amgen; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Sarah Danson
Consulting or Advisory Role - Inca Pharma (Inst)
Speakers' Bureau - BMS Brazil; Boehringer Ingelheim
Research Funding - Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Virttu Biologics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD
 
Ernest Marshall
No Relationships to Disclose
 
Stephen Houston
No Relationships to Disclose
 
Ruth E. Board
No Relationships to Disclose
 
Ashita Marie Waterston
Speakers' Bureau - MSD
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Jenny Penelope Nobes
No Relationships to Disclose
 
Mark Harries
Honoraria - Amgen; Bristol-Myers Squibb; Eisai; MSD; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Pierre Fabre; Roche
Speakers' Bureau - Eisai; Genomic Health
 
Satish Kumar
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Janssen; MSD
 
Gemma Young
Employment - Genomic Health (I)
 
Emily Barker
No Relationships to Disclose
 
Janet Dunn
No Relationships to Disclose
 
Mark R. Middleton
Honoraria - Bristol-Myers Squibb; Merck; Roche; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Merck